WPRIM Management System> DCMS> Diabetes & Metabolism Journal> 2019> 43> 3

Volume: 43 Issue: 3

1. Response: Predictors of the Therapeutic Efficacy and Consideration of the Best Combination Therapy of Sodium-Glucose Co-transporter 2 Inhibitors (Diabetes Metab J 2019;43:158–73) Page:379—380
2. Letter: Predictors of the Therapeutic Efficacy and Consideration of the Best Combination Therapy of Sodium-Glucose Co-transporter 2 Inhibitors (Diabetes Metab J 2019;43:158–73) Page:377—378
3. Serum R-Spondin 1 Is a New Surrogate Marker for Obesity and Insulin Resistance Page:368—376
4. Association of Visit-to-Visit Variability of Blood Pressure with Cardiovascular Disease among Type 2 Diabetes Mellitus Patients: A Cohort Study Page:350—367
5. Oral Glucose Tolerance Testing Allows Better Prediction of Diabetes in Women with a History of Gestational Diabetes Mellitus Page:342—349
6. Diabetes Mellitus and Cause-Specific Mortality: A Population-Based Study Page:319—341
7. Effectiveness of Exercise Intervention in Reducing Body Weight and Glycosylated Hemoglobin Levels in Patients with Type 2 Diabetes Mellitus in Korea: A Systematic Review and Meta-Analysis Page:302—318
8. Acarbose Add-on Therapy in Patients with Type 2 Diabetes Mellitus with Metformin and Sitagliptin Failure: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Page:287—301
9. Efficacy and Safety of Voglibose Plus Metformin in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Trial Page:276—286
10. Diabetes Mellitus, Still Major Threat to Mortality from Various Causes Page:273—275
11. Understanding Bile Acid Signaling in Diabetes: From Pathophysiology to Therapeutic Targets Page:257—272
12. Mitochondrial Dysfunction in Adipocytes as a Primary Cause of Adipose Tissue Inflammation Page:247—256

©2019 - Present World Health Organization Regional Office for the Western Pacific. All Rights Reserved.